The degradation of human glomerular basement membrane with purified lysosomal proteinases: evidence for the pathogenic role of the polymorphonuclear leucocyte in glomerulonephritis.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 630800)

Published in Clin Sci Mol Med on March 01, 1978

Authors

M Davies, A J Barrett, J Travis, E Sanders, G A Coles

Articles citing this

Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest (1997) 2.03

Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. Biochem J (1982) 1.66

Degradation of human glomerular basement membrane by stimulated neutrophils. Activation of a metalloproteinase(s) by reactive oxygen metabolites. J Clin Invest (1987) 1.38

The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J Exp Med (1988) 1.35

Affinity purification and biochemical characterization of histolysin, the major cysteine proteinase of Entamoeba histolytica. Biochem J (1988) 1.26

Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase. J Exp Med (1989) 1.18

Type 1 fimbriate Escherichia coli stimulates a unique pattern of degranulation by human polymorphonuclear leukocytes. Infect Immun (1988) 1.09

The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells. Biochem J (1988) 1.09

Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest (1996) 1.06

Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G. Am J Pathol (1990) 1.03

Elastase-like enzymes in human neutrophils localized by ultrastructural cytochemistry. J Cell Biol (1980) 0.94

Human kidney cathepsins B and L. Characterization and potential role in degradation of glomerular basement membrane. Biochem J (1988) 0.91

Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors. Biochem J (1994) 0.90

Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment. Eur J Med Res (2010) 0.85

Loss and rearrangement of glomerular basement membrane laminin during acute nephrotoxic nephritis in the rat. Am J Pathol (1990) 0.81

Effect of glomerular basement membrane on the initiation of chemiluminescence and lysosomal enzyme release in human polymorphonuclear leucocytes: an in vitro model of glomerular disease. Immunology (1984) 0.76

Suppression of development of glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: relations between intercellular adhesion molecule-1 expression on endothelial cells and leucocyte accumulation in glomeruli. Int J Exp Pathol (1994) 0.75

Re-Examining Neutrophil Participation in GN. J Am Soc Nephrol (2017) 0.75

Effect of oral camostat mesilate on hematuria and/or proteinuria in children. Pediatr Nephrol (2004) 0.75

Antineutrophil cytoplasmic antibodies (ANCA) and vasculitis. Clin Rheumatol (1990) 0.75

Articles by these authors

(truncated to the top 100)

Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta (1986) 13.69

The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry (1996) 8.16

The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry (1992) 7.36

A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res (1982) 7.12

The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Arch Gen Psychiatry (1985) 6.91

Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol (1981) 6.84

Human plasma proteinase inhibitors. Annu Rev Biochem (1983) 6.61

The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem J (1973) 5.99

Evolutionary families of peptidases. Biochem J (1993) 5.81

L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J (1982) 5.67

Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med (2000) 4.99

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia (2008) 4.62

Potassium-dependant mutants of Escherichia coli K-12. J Bacteriol (1970) 4.44

Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA (1995) 4.40

Reducing HIV sexual risk behaviors among runaway adolescents. JAMA (1991) 4.10

Human cathepsin B1. Purification and some properties of the enzyme. Biochem J (1973) 4.06

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87

Epidemiology of depressive mood in adolescents: an empirical study. Arch Gen Psychiatry (1982) 3.81

The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule. Biochem J (1979) 3.58

Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry (1976) 3.57

Evolutionary families of metallopeptidases. Methods Enzymol (1995) 3.48

A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med (1996) 3.20

A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. Anal Biochem (1979) 3.17

Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem (1980) 3.14

Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci. J Infect Dis (1969) 3.09

Cathepsin D. Purification of isoenzymes from human and chicken liver. Biochem J (1970) 3.09

The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem (1994) 3.07

Families of serine peptidases. Methods Enzymol (1994) 2.94

The consequences in young adulthood of adolescent drug involvement. An overview. Arch Gen Psychiatry (1986) 2.93

A new assay for cathepsin B1 and other thiol proteinases. Anal Biochem (1972) 2.93

Lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins. J Biol Chem (1994) 2.90

Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nurs (1993) 2.87

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med (2001) 2.75

High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet (2000) 2.75

Cause for concern? Br Dent J (2004) 2.74

Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry (1997) 2.70

Selective removal of albumin from plasma by affinity chromatography. Clin Chim Acta (1973) 2.69

The Diagnostic Interview Schedule for Children-Revised Version (DISC-R): I. Preparation, field testing, interrater reliability, and acceptability. J Am Acad Child Adolesc Psychiatry (1993) 2.69

The composition and physicochemical properties of hyaluronic acids prepared from ox synovial fluid and from a case of mesothelioma. Biochem J (1965) 2.68

Cathepsin B1. A lysosomal enzyme that degrades native collagen. Biochem J (1974) 2.65

Cathepsin D. Characteristics of immunoinhibition and the confirmation of a role in cartilage breakdown. Biochem J (1971) 2.60

MEROPS: the peptidase database. Nucleic Acids Res (1999) 2.60

The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. J Biol Chem (1979) 2.57

Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis. Lancet (1977) 2.53

Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes. Diabet Med (2007) 2.48

Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet (1979) 2.48

Death of Diana, Princess of Wales. Her death and funeral rate as traumatic stressors. BMJ (1997) 2.47

Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin. Antimicrob Agents Chemother (1973) 2.47

Primary structure of human neutrophil elastase. Proc Natl Acad Sci U S A (1987) 2.45

Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med (1968) 2.44

An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature (1998) 2.44

The NIMH Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study: background and methodology. J Am Acad Child Adolesc Psychiatry (1996) 2.43

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess (2005) 2.42

Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum. Biochem J (1983) 2.42

Isolation and properties of human plasma alpha-1-proteinase inhibitor. Biochemistry (1974) 2.40

Aetiology of chronic heart block. A clinico-pathological correlation in 65 cases. Br Heart J (1969) 2.31

Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 (2000) 2.29

Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry (1987) 2.24

Pectic polysaccharides of growing plant tissues. Biochem J (1967) 2.24

Acute renal failure associated with non-fulminant hepatitis A. Clin Nephrol (1993) 2.24

An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23

Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet (1981) 2.22

Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem J (1980) 2.20

Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut (2007) 2.20

Neutral proteinases of human spleen. Purification and criteria for homogeneity of elastase and cathepsin G. Biochem J (1976) 2.17

Human liver cathepsin L. Biochem J (1985) 2.16

Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma. Biochem J (1976) 2.15

Lysosomal acid proteinase of rabbit liver. Biochem J (1967) 2.12

The interaction of alpha2-macroglobulin with proteinases. Binding and inhibition of mammalian collagenases and other metal proteinases. Biochem J (1974) 2.11

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood (2001) 2.11

Digestion of an exogenous protein by rat yolk-sac cultured in vitro. Biochem J (1971) 2.07

The inhibition of tissue acid proteinases by pepstatin. Biochem J (1972) 2.06

Polycystic kidney disease re-evaluated: a population-based study. Q J Med (1991) 2.05

Test-retest reliability of the Diagnostic Interview Schedule for Children (DISC 2.1). Parent, child, and combined algorithms. Arch Gen Psychiatry (1995) 2.05

Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem (1986) 2.03

The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect Immun (1995) 2.03

CA074 methyl ester: a proinhibitor for intracellular cathepsin B. Arch Biochem Biophys (1992) 2.03

Changes in rheumatology out-patient workload over 12 years in the South West of England. Rheumatology (Oxford) (2003) 2.02

Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun (1979) 2.00

Adult sequelae of adolescent depressive symptoms. Arch Gen Psychiatry (1986) 1.99

Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem (1992) 1.99

Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci (2006) 1.99

Molecular cloning and structural characterization of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J Biol Chem (1995) 1.98

Hepatitis-associated aplastic anemia. N Engl J Med (1997) 1.98

Families of cysteine peptidases. Methods Enzymol (1994) 1.98

Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem (1992) 1.96

Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun (1999) 1.96

Diagnosis of DSM-III-R personality disorders by two structured interviews: patterns of comorbidity. Am J Psychiatry (1992) 1.91

The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: a review. Hum Reprod Update (2007) 1.91

Hypertension and convulsions in children receiving cyclosporin A. Lancet (1982) 1.89

Health risks associated with wastewater irrigation: an epidemiological study. Am J Public Health (1986) 1.89

Efficacy of rifampin in treatment of meningococcal carriers. N Engl J Med (1969) 1.89

Integrated regional haemodialysis and renal transplantation centre. Br Med J (1970) 1.89

Human cathepsin H. Biochem J (1980) 1.88

An improved color reagent for use in Barrett's assay of Cathepsin B. Anal Biochem (1976) 1.87

Why Eric Mazur Brings Chaos--Not Chaos Theory--to Physics. Science (1994) 1.87

Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. BMJ (1989) 1.86

Creating a shared vision of out of hours care: using rapid appraisal methods to create an interagency, community oriented, approach to service development. BMJ (1996) 1.86

Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States. Drug Alcohol Depend (1997) 1.84